Skip to main content
Clinical Trials/ACTRN12612000689875
ACTRN12612000689875
Not Yet Recruiting
N/A

Prospective detection of vestibular abnormalities resulting from the administration of Gentamicin and documentation of their subsequent recovery.

Capital and Coast District Health Board (CCDHB)0 sites500 target enrollmentJune 27, 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Gentamicin vestibulotoxicity
Sponsor
Capital and Coast District Health Board (CCDHB)
Enrollment
500
Status
Not Yet Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 27, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Capital and Coast District Health Board (CCDHB)

Eligibility Criteria

Inclusion Criteria

  • Participants must: be able to give consent prior to or while being treated at Wellington Hospital or Hutt Valley Hospital. The only inclusion criteria at day 1 will be treatment or pending treatment with IV Gentamicin within 24 hrs of measurement of the VOR gain.

Exclusion Criteria

  • Patients so unwell that they do not wish to have their head moved or who decline testing or who are regarded by the examiner as being too ill to adequately co\-operate.

Outcomes

Primary Outcomes

Not specified

Similar Trials